Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease
Chronic stable angina affects approximately 10 million Americans, of whom more than 50% are older than 65 years. Angina is a more common manifestation of coronary heart disease in women than in men. The growing prevalence of recurring ischemia is probably due to residual coronary artery disease afte...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript
2019-01-01
|
| Series: | Cardiovascular Innovations and Applications |
| Subjects: | |
| Online Access: | https://www.ingentaconnect.com/content/cscript/cvia/2019/00000003/00000003/art00002 |
| id |
doaj-77f67d278f6549a682a8fef406885d81 |
|---|---|
| record_format |
Article |
| spelling |
doaj-77f67d278f6549a682a8fef406885d812020-11-24T23:59:01ZengCompuscriptCardiovascular Innovations and Applications2009-86182009-87822019-01-013327928310.15212/CVIA.2017.0074Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart DiseaseC. Richard Conti, MD, MACC0University of Florida Medical School, Gainesville, FL, USAChronic stable angina affects approximately 10 million Americans, of whom more than 50% are older than 65 years. Angina is a more common manifestation of coronary heart disease in women than in men. The growing prevalence of recurring ischemia is probably due to residual coronary artery disease after percutaneous coronary intervention or coronary artery bypass grafting. Those with angina have a high socioeconomic burden that significantly limits functional capacity and impairs quality of life, and includes the high cost of care. The presence of common comorbidities, including diabetes, is associated with poorer outcomes.https://www.ingentaconnect.com/content/cscript/cvia/2019/00000003/00000003/art00002stable anginaepidemiologypathophysiology |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
C. Richard Conti, MD, MACC |
| spellingShingle |
C. Richard Conti, MD, MACC Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease Cardiovascular Innovations and Applications stable angina epidemiology pathophysiology |
| author_facet |
C. Richard Conti, MD, MACC |
| author_sort |
C. Richard Conti, MD, MACC |
| title |
Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease |
| title_short |
Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease |
| title_full |
Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease |
| title_fullStr |
Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease |
| title_full_unstemmed |
Epidemiology, Pathophysiology, and Therapeutic Targets in Stable Ischemic Heart Disease |
| title_sort |
epidemiology, pathophysiology, and therapeutic targets in stable ischemic heart disease |
| publisher |
Compuscript |
| series |
Cardiovascular Innovations and Applications |
| issn |
2009-8618 2009-8782 |
| publishDate |
2019-01-01 |
| description |
Chronic stable angina affects approximately 10 million Americans, of whom more than 50% are older than 65 years. Angina is a more common manifestation of coronary heart disease in women than in men. The growing prevalence of recurring ischemia is probably due to residual coronary artery disease after percutaneous coronary intervention or coronary artery bypass grafting. Those with angina have a high socioeconomic burden that significantly limits functional capacity and impairs quality of life, and includes the high cost of care. The presence of common comorbidities, including diabetes, is associated with poorer outcomes. |
| topic |
stable angina epidemiology pathophysiology |
| url |
https://www.ingentaconnect.com/content/cscript/cvia/2019/00000003/00000003/art00002 |
| work_keys_str_mv |
AT crichardcontimdmacc epidemiologypathophysiologyandtherapeutictargetsinstableischemicheartdisease |
| _version_ |
1725448658141315072 |